GBIO
Generation Bio Co. (GBIO)
$
69About Generation Bio Co. (GBIO)
Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.
Details
Daily high
$0.73
Daily low
$0.68
Price at open
$0.70
52 Week High
$4.65
52 Week Low
$0.60
Market cap
46.4M
Dividend yield
0.00%
Volume
66,896
Avg. volume
432,025
P/E ratio
-.32
Generation Bio Co. News
Details
Daily high
$0.73
Daily low
$0.68
Price at open
$0.70
52 Week High
$4.65
52 Week Low
$0.60
Market cap
46.4M
Dividend yield
0.00%
Volume
66,896
Avg. volume
432,025
P/E ratio
-.32